Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IBTA | RDVT |
|---|---|---|
| Price | $41.53 | $77.85 |
| Change today | ▲ 1.39% | ▼ 0.22% |
| Market cap | $962.23M | $1.25B |
| Return, 3 months | +30.8% | +16.0% |
| Return, year to date | +82.7% | +36.7% |
| Return, 1 year | +36.5% | +49.3% |
| P/E (TTM) | -88.4 | 68.3 |
| P/B | 4.0 | 11.2 |
| P/E percentile vs own 5y | 9th | 40th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +3.3% | +22.7% |
| Net profit growth (YoY) | -149.4% | +84.7% |
| Gross margin | 78.2% | 84.7% |
| Operating margin | -3.5% | 17.9% |
| Net margin | -3.2% | 16.5% |
| Return on equity | -3.7% | 15.8% |
| Analyst target vs. price | -12.5% | +7.3% |
| Analyst buy share | 33% | 100% |
| RSI (14) | 59 | 55 |
| 30-day volatility | 29.4% | 38.2% |
| Max drawdown, 1 year | -45.1% | -42.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
